Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesColistin in the 21st century
Current Opinion in Infectious Diseases, 11/02/09
Nation RL et al. – Because few, if any, new antibiotics with activity against multidrug–resistant Gram–negative bacteria will be available within the next several years, it is essential that colistin is used in ways that maximize its antibacterial efficacy and minimize toxicity and development of resistance. Recent developments have improved use of colistin in the 21st century.
Related Articles
Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature
International Journal of Infectious Diseases, 11/16/09
Relevance Score: 85%
Penetration of Colistin into Cerebrospinal Fluid
Antimicrobial Agents and Chemotherapy, 11/05/09
Relevance Score: 85%
Colistin and polymyxin B: A re-emergence
Indian Journal of Critical Care Medicine, 10/09/09
Relevance Score: 82%
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum Beta-Lactamases GES-1 and GES-5 in Spain
Antimicrobial Agents and Chemotherapy, 11/03/09
Relevance Score: 80%
Emerging Infections in Burns
Surgical Infections, 10/08/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Review: erythropoiesis-stimulating agents increase mortality in patients with cancer
Evidence-Based Medicine, 12/07/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy
Clinical Infectious Diseases, 12/07/09
The Impact of The President’s Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and Why It Remains Essential
Clinical Infectious Diseases, 12/07/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor